eWeLL's First Participation in Kabu Berry Lab IR Seminar
On June 18, 2025, at 8 PM, eWeLL, a leading company in home care digital transformation, will be making its debut at the "Kabu Berry Lab IR Seminar" aimed at individual investors. This event promises to be an informative session as eWeLL shares insights about its business model, growth strategies, and future outlook.
Understanding eWeLL
Founded in Osaka, eWeLL has established a strong reputation for enhancing efficiency in home healthcare services using innovative IT solutions. The company is family-owned and led by President Norito Nakano, who has been instrumental in driving its mission to bring happiness to people's lives through improved healthcare services. With the increasing demand for home care, eWeLL's focus on creating digital tools enables healthcare professionals to optimize their tasks, significantly improving the quality of care for patients.
Seminar Highlights
The seminar will not only cover eWeLL's business overview but will also provide an opportunity for participants to engage directly in a Q&A session with President Nakano. This interactive format aims to deepen individual investors' understanding of eWeLL and its role in the healthcare sector. High growth rates, impressive profit margins, and strategic use of technology, including generative AI, are key aspects of eWeLL’s growth strategy that will be discussed at the seminar.
Key Points About eWeLL
- - Social Impact: eWeLL is dedicated to solving societal challenges by contributing to the home healthcare sector, which is growing at over 10% annually. The company's SaaS solutions are tailored for home nursing services, essential in Japan’s aging society.
- - High Efficiency and Growth: eWeLL ranks 23rd out of 3,849 listed companies in operational profit margins, boasting an impressive 43.9%. The company has consistently maintained a sales growth rate of over 25%. This robust business model promises sustainable returns for investors.
- - Market Share: The company’s electronic medical record system, "iBow," has secured a substantial market share, currently used by over 17% of home nursing stations across Japan.
- - Utilization of Generative AI: The introduction of generative AI functions has enabled about 30% of users to transition to paid services, highlighting eWeLL's innovative approach to technology integration.
Event Participation
The Kabu Berry Lab is known for hosting over 140 seminars annually, specifically designed for individual investors. Unlike conventional IR presentations, these sessions allow ample time for questions, fostering in-depth discussions between companies and their investors. In addition, the seminar will be streamed online via Zoom, YouTube, and X (formerly Twitter), ensuring easy access for participants.
For further details and to register for the seminar, visit the following link:
Kabu Berry Lab IR Seminar Registration.
About eWeLL
Established in June 2012, eWeLL has been pivotal in promoting IT solutions in the home healthcare industry. The company's flagship products, such as "iBow" for electronic nursing records and the matching platform "Care Log," assist healthcare professionals across all 47 prefectures in Japan. With over 54,000 nursing professionals utilizing these tools daily, eWeLL plays an essential role in providing care for over 740,000 home patients.
For more information, visit eWeLL's official site:
eWeLL Official Website.
eWeLL continues to receive accolades, being recognized in several awards, including the Minister of Economy, Trade and Industry Award in 2021, and the Japan Venture Awards in 2022. With plans for future recognition in 2025, eWeLL demonstrates consistent progress and an unwavering commitment to excellence in the healthcare sector.